USPTO serial 90430359
ECOPLANET
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- COHEN, ROBERT ANDREW
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ECOPLANET?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Scott H. Blackman
Scott H. Blackman Booth Udall Fuller, PLC1255 W. Rio Salado Pkwy., Ste. 215Tempe, AZ 85281United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 004 | candles | ACTIVE | — |
| 005 | antimicrobial preparations and substances for the prevention, inhibition, treatment, and disinfection of bacterial, fungal, and other microbial infections, conditions, and growth in or near humans and animals and their environs, including maintaining hygiene in and on surfaces and materials for preparation of food and beverages, waste accumulation and disposal, and in living and work spaces; dietary supplements for animal and human consumption; nutritional supplements for human and animal consumption; oral electrolytes in the nature of nutritional supplements for human and animal consumption; animal feed additives for use as nutritional supplements; animal feed supplements; pharmaceutical preparations for the inhibition of bacterial, fungal and microbial activity, and for the prevention and treatment of bacterial, fungal and microbial infections in humans and animals; disinfectants; anti-infective preparations and substances; all-purpose disinfectants with anti-bacterial, anti-fungal, and anti-microbial properties; disinfectant preparations having antibacterial, antifungal, and antimicrobial activity for hygienic and sanitary purposes; anti-fungal preparations; fungicides and anti-fungal preparations and substances; odor reducing compounds in the nature of antimicrobial preparations for reducing odors on various surfaces, for general use; antimicrobial preparations for the prevention, care and treatment of wounds and infections; veterinary preparations for the prevention, care and treatment of wounds and infections; topical antimicrobial preparations for dermatologic use; Antimicrobial preparations for inhibiting microbiological growth and decomposition in food, beverages, animal feed and pharmaceuticals; hand sanitizer; medicated mouthwash; medical foods as dietary foods adapted for medical use; medical foods, namely, dietetic food that is intended for the specific dietary management of a disease or condition; medicated feed for livestock and companion pets; anti-diarrheal agents for medical purposes; pharmaceutical preparations, namely, preparations that provide relief of symptoms of diarrhea and GI tract disorders; pharmaceutical products and preparations for the prevention and treatment of infectious or parasitic diseases; pharmaceutical preparations and substances for the treatment of viral and respiratory related diseases and disorders; pharmaceutical preparations for skin care; pharmaceutical preparations and substances for the treatment of damaged skin and tissue, and problematic skin conditions; pharmaceutical preparations and medicines for the treatment and prevention of GI Tract disorders, enteric diseases, irritable bowel syndrome, and infectious diseases; pharmaceutical preparations, namely, microbiome modulating treatments for treating GI Tract disorders, enteric diseases, irritable bowel syndrome, and infectious diseases; pharmaceutical preparations for treating oral microbiome dysbiosis that results from the use of antibiotic medications for the restoration of balance to a perturbed human oral and nasal microbiome; pharmaceutical preparations for treatment and prevention of animal diseases, namely, mastitis in livestock; pharmaceutical preparations for the treatment or prevention of disorders or diseases caused by bacteria; probiotic and prebiotic supplement formulations in the form of capsules, suppositories, and lyophilized powders all for the developing infant gut microbiome, for supporting healthy vaginal microbiomes in pregnant women and supporting healthy breastfeeding, and for increasing strains of beneficial bacteria in infants, children, and adolescents; probiotic supplement formulations for veterinary use, namely, antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis; probiotic supplement formulations for medical use, namely, oral formulations, formulations that deliver a microbiome into a human or animal, and formulations that deliver microbiome into skin, hair, mouth, gut, blood, tissue, fluid or organ of a human or animal; veterinary preparations active in the microbiome space, namely, probiotic and prebiotic supplements; veterinary preparations, namely, antibacterial preparations, microbiome modulating preparations, anti-infective preparations and antibacterial prophylaxis preparations, and antibacterial diagnostic preparations; microbiome modulators for veterinary purposes, namely, animal feed additives for use in animals feed to assist in digestion, growth or wellbeing; microbiome modulators for medical purposes, namely, as modulators of activity of pharmaceuticals in humans and animals; veterinary preparations for the treatment of scours, diarrhea, and infectious diseases; veterinary preparations for providing antibodies for the protection against disease; preparations for destroying parasites; odor neutralizing preparations for use on garbage and dumpsters; poultry litter treatment preparation, namely, deodorizers added to poultry litter to control the ammonia odor from animal waste materials; deodorizing preparations for commercial and industrial use for treatment of poultry litter; odor control agents, namely, air deodorizing preparations in aerosol form; all-purpose disinfectants for infection control and prevention and biosecurity; antimicrobial, antiviral, and anti-protozoal disinfectant for biosecurity and farm use | ACTIVE | — |
| 031 | oral electrolyte drink mix for animals | ACTIVE | — |
| 032 | sports drinks containing electrolytes for human consumption | ACTIVE | — |
| 035 | distributorship services in the field of antimicrobial preparations and substances for the prevention, inhibition, treatment, and disinfection of bacterial, fungal, and other microbial infections, conditions, and activity in or near humans and animals and their environs, including maintaining hygiene in and on surfaces and materials for preparation of food and beverages, waste accumulation and disposal, and in living and work spaces, dietary supplements for animal and human consumption, nutritional supplements for human and animal consumption, oral electrolytes for human and animal consumption, animal feed additives for use as nutritional supplements, animal feed supplements, pharmaceutical preparations for the inhibition of bacterial, fungal and microbial activity, and for the prevention and treatment of bacterial, fungal and microbial infections in humans and animals, disinfectants, anti-infective preparations and substances, all-purpose disinfectants with anti-bacterial, anti-fungal, and anti-microbial properties, disinfectant preparations having antibacterial, antifungal, and antimicrobial activity for hygienic and sanitary purposes, anti-fungal preparations, fungicides and anti-fungal preparations and substances, odor reducing compounds in the nature of antimicrobial preparations for reducing odors, antimicrobial preparations for the prevention, care and treatment of wounds and infections, veterinary preparations for the prevention, care and treatment of wounds and infections, topical antimicrobial preparations for dermatologic use, antimicrobial preparations for inhibiting microbiological activity and decomposition in food, beverages, animal feed and pharmaceuticals, candles, hand sanitizer, medicated mouthwash, medical foods as dietary foods adapted for medical use, medical foods, namely, dietetic food that is intended for the specific dietary management of a disease or condition, medicated feed for livestock and companion pets, anti-diarrheal agents, pharmaceutical preparations, namely, preparations that provide relief of symptoms of diarrhea and GI tract disorders, pharmaceutical products and preparations for the prevention and treatment of infectious or parasitic diseases, pharmaceutical preparations and substances for the treatment of viral and respiratory related diseases and disorders, pharmaceutical preparations for skin care, pharmaceutical preparations and substances for the treatment of damaged skin and tissue, and problematic skin conditions, pharmaceutical preparations and medicines for the treatment and prevention of GI Tract disorders, enteric diseases, irritable bowel syndrome, and infectious diseases, pharmaceutical preparations, namely, microbiome modulating treatments, pharmaceutical preparations for oral microbiome dysbiosis resulting from the use of antibiotic medications and consumer health interventions for the restoration of balance to a perturbed human oral and nasal microbiome, pharmaceutical preparations for treatment and prevention of animal diseases, namely, mastitis in livestock, pharmaceutical preparations for the treatment or prevention of disorders or diseases caused by bacteria, probiotic and prebiotic formulations, namely, capsules, suppositories, and lyophilized powders for the developing infant gut microbiome, for supporting healthy vaginal microbiomes in pregnant women and supporting healthy breastfeeding, and for increasing strains of beneficial bacteria in infants, children, and adolescents, probiotic formulations for veterinary use, namely, antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis, probiotic formulations for medical use, namely, oral formulations, formulations for delivery to a microbiome in a human or animal, and formulations for delivery to skin, hair, mouth, gut, blood or a tissue, fluid or organ of a human or animal, veterinary preparations active in the microbiome space, veterinary preparations, namely, antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis, and medical diagnostics, microbiome modulators for veterinary purposes, namely, animal feed additives for use in animals feed to assist in digestion, growth or wellbeing, microbiome modulators for medical purposes, namely, as modulators of activity of pharmaceuticals in humans and animals, veterinary preparations for the treatment of scours, diarrhea, and infectious diseases, veterinary preparations for providing antibodies for the protection against disease, preparations for destroying parasites, odor neutralizing preparations for use on garbage and dumpsters, poultry litter treatment preparation, namely, deodorizers added to poultry litter to control the ammonia odor from animal waste materials, deodorizing preparations for commercial and industrial use for treatment of poultry litter, odor control agents, namely, air deodorizing preparations in aerosol form, all-purpose disinfectants for infection control and prevention and biosecurity, disinfectant for biosecurity and farm use; retail and wholesale store services featuring antimicrobial preparations and substances for the prevention, inhibition, treatment, and disinfection of bacterial, fungal, and other microbial infections, conditions, and activity in or near humans and animals and their environs, including maintaining hygiene in and on surfaces and materials for preparation of food and beverages, waste accumulation and disposal, and in living and work spaces, dietary supplements for animal and human consumption, nutritional supplements for human and animal consumption, oral electrolytes for human and animal consumption, animal feed additives for use as nutritional supplements, animal feed supplements, pharmaceutical preparations for the inhibition of bacterial, fungal and microbial activity, and for the prevention and treatment of bacterial, fungal and microbial infections in humans and animals, disinfectants, anti-infective preparations and substances, all-purpose disinfectants with anti-bacterial, anti-fungal, and anti-microbial properties, disinfectant preparations having antibacterial, antifungal, and antimicrobial activity for hygienic and sanitary purposes, anti-fungal preparations, fungicides and anti-fungal preparations and substances, odor reducing compounds in the nature of antimicrobial preparations for reducing odors, antimicrobial preparations for the prevention, care and treatment of wounds and infections, veterinary preparations for the prevention, care and treatment of wounds and infections, topical antimicrobial preparations for dermatologic use, Antimicrobial preparations for inhibiting microbiological activity and decomposition in food, beverages, animal feed and pharmaceuticals, candles, hand sanitizer, medicated mouthwash, medical foods as dietary foods adapted for medical use, medical foods, namely, dietetic food that is intended for the specific dietary management of a disease or condition, medicated feed for livestock and companion pets, anti-diarrheal agents, pharmaceutical preparations, namely, preparations that provide relief of symptoms of diarrhea and GI tract disorders, pharmaceutical products and preparations for the prevention and treatment of infectious or parasitic diseases, pharmaceutical preparations and substances for the treatment of viral and respiratory related diseases and disorders, pharmaceutical preparations for skin care, pharmaceutical preparations and substances for the treatment of damaged skin and tissue, and problematic skin conditions, pharmaceutical preparations and medicines for the treatment and prevention of GI Tract disorders, enteric diseases, irritable bowel syndrome, and infectious diseases, pharmaceutical preparations, namely, microbiome modulating treatments, pharmaceutical preparations for oral microbiome dysbiosis resulting from the use of antibiotic medications and consumer health interventions for the restoration of balance to a perturbed human oral and nasal microbiome, pharmaceutical preparations for treatment and prevention of animal diseases, namely, mastitis in livestock, pharmaceutical preparations for the treatment or prevention of disorders or diseases caused by bacteria, probiotic and prebiotic formulations, namely, capsules, suppositories, and lyophilized powders for the developing infant gut microbiome, for supporting healthy vaginal microbiomes in pregnant women and supporting healthy breastfeeding, and for increasing strains of beneficial bacteria in infants, children, and adolescents, probiotic formulations for veterinary use, namely, antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis, probiotic formulations for medical use, namely, oral formulations, formulations for delivery to a microbiome in a human or animal, and formulations for delivery to skin, hair, mouth, gut, blood or a tissue, fluid or organ of a human or animal, veterinary preparations active in the microbiome space, veterinary preparations, namely, antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis, and medical diagnostics, microbiome modulators for veterinary purposes, namely, animal feed additives for use in animals feed to assist in digestion, growth or wellbeing, microbiome modulators for medical purposes, namely, as modulators of activity of pharmaceuticals in humans and animals, veterinary preparations for the treatment of scours, diarrhea, and infectious diseases, veterinary preparations for providing antibodies for the protection against disease, preparations for destroying parasites, odor neutralizing preparations for use on garbage and dumpsters, poultry litter treatment preparation, namely, deodorizers added to poultry litter to control the ammonia odor from animal waste materials, deodorizing preparations for commercial and industrial use for treatment of poultry litter, odor control agents, namely, air deodorizing preparations in aerosol form, all-purpose disinfectants for infection control and prevention and biosecurity, disinfectant for biosecurity and farm use; online retail and online wholesale store services featuring antimicrobial preparations and substances for the prevention, inhibition, treatment, and disinfection of bacterial, fungal, and other microbial infections, conditions, and activity in or near humans and animals and their environs, including maintaining hygiene in and on surfaces and materials for preparation of food and beverages, waste accumulation and disposal, and in living and work spaces, dietary supplements for animal and human consumption, nutritional supplements for human and animal consumption, oral electrolytes for human and animal consumption, animal feed additives for use as nutritional supplements, animal feed supplements, pharmaceutical preparations for the inhibition of bacterial, fungal and microbial activity, and for the prevention and treatment of bacterial, fungal and microbial infections in humans and animals, disinfectants, anti-infective preparations and substances, all-purpose disinfectants with anti-bacterial, anti-fungal, and anti-microbial properties, disinfectant preparations having antibacterial, antifungal, and antimicrobial activity for hygienic and sanitary purposes, anti-fungal preparations, fungicides and anti-fungal preparations and substances, odor reducing compounds in the nature of antimicrobial preparations for reducing odors, antimicrobial preparations for the prevention, care and treatment of wounds and infections, veterinary preparations for the prevention, care and treatment of wounds and infections, topical antimicrobial preparations for dermatologic use, Antimicrobial preparations for inhibiting microbiological activity and decomposition in food, beverages, animal feed and pharmaceuticals, candles, hand sanitizer, medicated mouthwash, medical foods as dietary foods adapted for medical use, medical foods, namely, dietetic food that is intended for the specific dietary management of a disease or condition, medicated feed for livestock and companion pets, anti-diarrheal agents, pharmaceutical preparations, namely, preparations that provide relief of symptoms of diarrhea and GI tract disorders, pharmaceutical products and preparations for the prevention and treatment of infectious or parasitic diseases, pharmaceutical preparations and substances for the treatment of viral and respiratory related diseases and disorders, pharmaceutical preparations for skin care, pharmaceutical preparations and substances for the treatment of damaged skin and tissue, and problematic skin conditions, pharmaceutical preparations and medicines for the treatment and prevention of GI Tract disorders, enteric diseases, irritable bowel syndrome, and infectious diseases, pharmaceutical preparations, namely, microbiome modulating treatments, pharmaceutical preparations for oral microbiome dysbiosis resulting from the use of antibiotic medications and consumer health interventions for the restoration of balance to a perturbed human oral and nasal microbiome, pharmaceutical preparations for treatment and prevention of animal diseases, namely, mastitis in livestock, pharmaceutical preparations for the treatment or prevention of disorders or diseases caused by bacteria, probiotic and prebiotic formulations, namely, capsules, suppositories, and lyophilized powders for the developing infant gut microbiome, for supporting healthy vaginal microbiomes in pregnant women and supporting healthy breastfeeding, and for increasing strains of beneficial bacteria in infants, children, and adolescents, probiotic formulations for veterinary use, namely, antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis, probiotic formulations for medical use, namely, oral formulations, formulations for delivery to a microbiome in a human or animal, and formulations for delivery to skin, hair, mouth, gut, blood or a tissue, fluid or organ of a human or animal, veterinary preparations active in the microbiome space, veterinary preparations, namely, antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis, and medical diagnostics, microbiome modulators for veterinary purposes, namely, animal feed additives for use in animals feed to assist in digestion, growth or wellbeing, microbiome modulators for medical purposes, namely, as modulators of activity of pharmaceuticals in humans and animals, veterinary preparations for the treatment of scours, diarrhea, and infectious diseases, veterinary preparations for providing antibodies for the protection against disease, preparations for destroying parasites, odor neutralizing preparations for use on garbage and dumpsters, poultry litter treatment preparation, namely, deodorizers added to poultry litter to control the ammonia odor from animal waste materials, deodorizing preparations for commercial and industrial use for treatment of poultry litter, odor control agents, namely, air deodorizing preparations in aerosol form, all-purpose disinfectants for infection control and prevention and biosecurity, disinfectant for biosecurity and farm use; marketing and advertising services in relation to the promotion of antimicrobial preparations and substances for the prevention, inhibition, treatment, and disinfection of bacterial, fungal, and other microbial infections, conditions, and activity in or near humans and animals and their environs, including maintaining hygiene in and on surfaces and materials for preparation of food and beverages, waste accumulation and disposal, and in living and work spaces, dietary supplements for animal and human consumption, nutritional supplements for human and animal consumption, oral electrolytes for human and animal consumption, animal feed additives for use as nutritional supplements, animal feed supplements, pharmaceutical preparations for the inhibition of bacterial, fungal and microbial activity, and for the prevention and treatment of bacterial, fungal and microbial infections in humans and animals, disinfectants, anti-infective preparations and substances, all-purpose disinfectants with anti-bacterial, anti-fungal, and anti-microbial properties, disinfectant preparations having antibacterial, antifungal, and antimicrobial activity for hygienic and sanitary purposes, anti-fungal preparations, fungicides and anti-fungal preparations and substances, odor reducing compounds in the nature of antimicrobial preparations for reducing odors, antimicrobial preparations for the prevention, care and treatment of wounds and infections, veterinary preparations for the prevention, care and treatment of wounds and infections, topical antimicrobial preparations for dermatologic use, Antimicrobial preparations for inhibiting microbiological activity and decomposition in food, beverages, animal feed and pharmaceuticals, candles, hand sanitizer, medicated mouthwash, medical foods as dietary foods adapted for medical use, medical foods, namely, dietetic food that is intended for the specific dietary management of a disease or condition, medicated feed for livestock and companion pets, anti-diarrheal agents, pharmaceutical preparations, namely, preparations that provide relief of symptoms of diarrhea and GI tract disorders, pharmaceutical products and preparations for the prevention and treatment of infectious or parasitic diseases, pharmaceutical preparations and substances for the treatment of viral and respiratory related diseases and disorders, pharmaceutical preparations for skin care, pharmaceutical preparations and substances for the treatment of damaged skin and tissue, and problematic skin conditions, pharmaceutical preparations and medicines for the treatment and prevention of GI Tract disorders, enteric diseases, irritable bowel syndrome, and infectious diseases, pharmaceutical preparations, namely, microbiome modulating treatments, pharmaceutical preparations for oral microbiome dysbiosis resulting from the use of antibiotic medications and consumer health interventions for the restoration of balance to a perturbed human oral and nasal microbiome, pharmaceutical preparations for treatment and prevention of animal diseases, namely, mastitis in livestock, pharmaceutical preparations for the treatment or prevention of disorders or diseases caused by bacteria, probiotic and prebiotic formulations, namely, capsules, suppositories, and lyophilized powders for the developing infant gut microbiome, for supporting healthy vaginal microbiomes in pregnant women and supporting healthy breastfeeding, and for increasing strains of beneficial bacteria in infants, children, and adolescents, probiotic formulations for veterinary use, namely, antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis, probiotic formulations for medical use, namely, oral formulations, formulations for delivery to a microbiome in a human or animal, and formulations for delivery to skin, hair, mouth, gut, blood or a tissue, fluid or organ of a human or animal, veterinary preparations active in the microbiome space, veterinary preparations, namely, antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis, and medical diagnostics, microbiome modulators for veterinary purposes, namely, animal feed additives for use in animals feed to assist in digestion, growth or wellbeing, microbiome modulators for medical purposes, namely, as modulators of activity of pharmaceuticals in humans and animals, veterinary preparations for the treatment of scours, diarrhea, and infectious diseases, veterinary preparations for providing antibodies for the protection against disease, preparations for destroying parasites, odor neutralizing preparations for use on garbage and dumpsters, poultry litter treatment preparation, namely, deodorizers added to poultry litter to control the ammonia odor from animal waste materials, deodorizing preparations for commercial and industrial use for treatment of poultry litter, odor control agents, namely, air deodorizing preparations in aerosol form, all-purpose disinfectants for infection control and prevention and biosecurity, disinfectant for biosecurity and farm use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Ecoplanet Environmental, LLC
- Other trademarks owned by Ecoplanet Environmental, LLC
- Other trademarks in Class 004
- Other trademarks in Class 005
- Other trademarks in Class 031
- Other trademarks in Class 032
- Other trademarks in Class 035
- Similar marks named ECOPLANET
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 18, 2024 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Nov 18, 2024 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Apr 10, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 9, 2024 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Apr 9, 2024 | EXT5 | SOU EXTENSION 5 FILED | — |
| Apr 9, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 6, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 4, 2023 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Oct 4, 2023 | EXT4 | SOU EXTENSION 4 FILED | — |
| Oct 4, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 8, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 6, 2023 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Apr 6, 2023 | EXT3 | SOU EXTENSION 3 FILED | — |
| Apr 6, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 7, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 5, 2022 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Oct 5, 2022 | EXT2 | SOU EXTENSION 2 FILED | — |
| Oct 5, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 9, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 7, 2022 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 7, 2022 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 7, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 4, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 4, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 4, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 12, 2021 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 17, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 17, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 28, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 12, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 12, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 12, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 12, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 12, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 1, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 24, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 2, 2021 | NWAP | NEW APPLICATION ENTERED | — |